Earnings Call · Q1 FY2022·2022-05-10

Q1 22EPS 0.00%·Rev n/aQ4 21EPS +7.41%·Rev n/aQ3 21EPS -18.18%·Rev n/aQ2 21EPS -2.78%·Rev n/a⚠ consensus missing

Aurinia Pharmaceuticals Inc. AUPH

Dana Lynch — Investor Relations or Communications

Peter Greenleaf — President and Chief Executive Officer

Joe Miller — Chief Financial Officer

+26.0%1d on move date+25.8% vs SPY3d+10.6%5d+22.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AUPH calls or request research access.

More AUPH calls Browse calls Request research access